JackH said...
Pratoman said...
But as you note, that cannot happen until there is a really definitive way, not with 95% surety but with 100% or 99.5% , to ackmpnowledge the fact that there are never absolute guarantees, to determine which PCs are truly indolent.
Did I say that?
You'd have to show me, because I don't think I would have said that.
I wouldn't have said that because I don't believe that.
Actually, the sentence fragments you wrote are a little confusing (it's a little late; that can be forgiven), but I don't think I would have said what I think you meant to write.
I don't think I would have said that because that sounds like someone who doesn't understand AS.
AS doesn't guarantee you will have an indolent tumor forever. That's not what AS is all about
.
AS means validating the stability of one's low grade tumor over time, and eventually moving safely to deferred treatment for the subset of men who show indications that treatment is appropriate.
Understanding AS means understanding that the cancer outcomes for those with similar low risk characteristics who undergo immediate treatment is no better or worse than those who follow AS. Possible future upgrades notwithstanding.
Sorry if I somehow, somewhere left a different impression. Where/when did I do that? Please let me know, and I'll try to go back and correct it. Thanks!This may have been, in part, me misinterpreting your statement, and in part, as you said, saying what i meant to say, using fragments....
You said ..
"
You have highlighted EXACTLY the reason, Pratoman, why many of the PC thought leaders are searching for the right way to redefine favorable-risk prostate cancers."
I took that to mean that PC thought leaders are looking for ways to classify pc as low risk and suitable for AS USING METHODS SUCH AS MRI and Genetic tests. Perhaps that is not what you meant. THE 95% /99.5% comment was my own, didnt mean to say that you said that.